NASDAQ:SNDX - Syndax Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$6.77 -0.38 (-5.31 %)
(As of 09/21/2018 04:00 PM ET)
Previous Close$7.15
Today's Range$6.47 - $7.34
52-Week Range$6.10 - $15.20
Volume608,804 shs
Average Volume341,487 shs
Market Capitalization$161.85 million
P/E Ratio-2.33
Dividend YieldN/A
Beta1.31

Headlines

Syndax Pharmaceuticals (NASDAQ SNDX) News Headlines

Source:
DateHeadline
Are Syndax Pharmaceuticals Inc’s (NASDAQ:SNDX) Interest Costs Too High?Are Syndax Pharmaceuticals Inc’s (NASDAQ:SNDX) Interest Costs Too High?
finance.yahoo.com - September 13 at 8:42 AM
Traders Buy High Volume of Call Options on Syndax Pharmaceuticals (SNDX)Traders Buy High Volume of Call Options on Syndax Pharmaceuticals (SNDX)
www.americanbankingnews.com - September 13 at 7:06 AM
Edited Transcript of SNDX earnings conference call or presentation 7-Aug-18 8:30pm GMTEdited Transcript of SNDX earnings conference call or presentation 7-Aug-18 8:30pm GMT
finance.yahoo.com - September 11 at 4:43 PM
Zacks: Brokerages Expect Syndax Pharmaceuticals Inc (SNDX) Will Announce Quarterly Sales of $380,000.00Zacks: Brokerages Expect Syndax Pharmaceuticals Inc (SNDX) Will Announce Quarterly Sales of $380,000.00
www.americanbankingnews.com - September 9 at 3:16 AM
Syndax Pharmaceuticals Inc (SNDX) Expected to Announce Earnings of -$0.76 Per ShareSyndax Pharmaceuticals Inc (SNDX) Expected to Announce Earnings of -$0.76 Per Share
www.americanbankingnews.com - September 7 at 12:44 PM
Syndax to Present at the International Association for the Study of Lung Cancer 19th World Conference on Lung CancerSyndax to Present at the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer
finance.yahoo.com - September 6 at 8:59 AM
Syndax Pharmaceuticals Inc (SNDX) Given Consensus Recommendation of "Buy" by BrokeragesSyndax Pharmaceuticals Inc (SNDX) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 1 at 7:12 AM
Syndax Announces Participation at Three Upcoming Investor ConferencesSyndax Announces Participation at Three Upcoming Investor Conferences
finance.yahoo.com - August 28 at 9:01 AM
Syndax: IOMachine Says Breast Cancer Trial Data Should Be A Major CatalystSyndax: IOMachine Says Breast Cancer Trial Data Should Be A Major Catalyst
seekingalpha.com - August 25 at 9:09 AM
Is the Options Market Predicting a Spike in Syndax (SNDX) Stock?Is the Options Market Predicting a Spike in Syndax (SNDX) Stock?
www.zacks.com - August 21 at 9:03 AM
Syndax Pharmaceuticals, Inc.s (SNDX) CEO Briggs Morrison on Q2 2018 Results - Earnings Call TranscriptSyndax Pharmaceuticals, Inc.'s (SNDX) CEO Briggs Morrison on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 9:06 AM
Syndax Pharmaceuticals (SNDX) Reports Q2 LossSyndax Pharmaceuticals (SNDX) Reports Q2 Loss
finance.yahoo.com - August 8 at 9:06 AM
Syndax: 2Q Earnings SnapshotSyndax: 2Q Earnings Snapshot
finance.yahoo.com - August 8 at 9:06 AM
The Growth of Stem Cell Applications are Contributing to the Cell Therapy Processing MarketThe Growth of Stem Cell Applications are Contributing to the Cell Therapy Processing Market
www.prnewswire.com - August 7 at 4:49 PM
Syndax Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Clinical and Business UpdateSyndax Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Clinical and Business Update
finance.yahoo.com - August 7 at 4:49 PM
Syndax to Announce Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 7, 2018Syndax to Announce Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 7, 2018
finance.yahoo.com - July 31 at 9:13 AM
Global Ocular Cancer Drug Development Pipeline Review 2018: 35 Products in Active Development Featuring ...Global Ocular Cancer Drug Development Pipeline Review 2018: 35 Products in Active Development Featuring ...
www.prnewswire.com - June 12 at 8:57 AM
Mining ASCO 2018s Gold, Part 7: Digest This News And Get Valuable InformationMining ASCO 2018's Gold, Part 7: Digest This News And Get Valuable Information
seekingalpha.com - May 31 at 9:19 AM
Syndax Pharmaceuticals, Nektar to Study NKTR-214 in Patients with PD-1 Refractory MelanomaSyndax Pharmaceuticals, Nektar to Study NKTR-214 in Patients with PD-1 Refractory Melanoma
www.nasdaq.com - May 31 at 9:19 AM
Syndax and Nektar Therapeutics team up in study of doublet therapy for advanced melanomaSyndax and Nektar Therapeutics team up in study of doublet therapy for advanced melanoma
seekingalpha.com - May 31 at 9:19 AM
Syndax Pharmaceuticals: Elucidating The Results Of The Phase 2 ENCORE 601 TrialSyndax Pharmaceuticals: Elucidating The Results Of The Phase 2 ENCORE 601 Trial
seekingalpha.com - May 28 at 10:05 AM
Syndax: One Step Backward, Two Forward?Syndax: One Step Backward, Two Forward?
seekingalpha.com - May 23 at 4:40 PM
A Requested Update On SyndaxA Requested Update On Syndax
seekingalpha.com - May 23 at 8:49 AM
Syndax Falls On ASCO Abstract Results, But Was Its Drop Justified At This Time?Syndax Falls On ASCO Abstract Results, But Was Its Drop Justified At This Time?
seekingalpha.com - May 21 at 9:18 AM
Blog Exposure - Syndax Pharma Shares Results of Phase-2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDABlog Exposure - Syndax Pharma Shares Results of Phase-2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA
finance.yahoo.com - May 21 at 9:18 AM
Syndax Pharmaceuticals: What Investors Can Expect From This Potential Grower?Syndax Pharmaceuticals: What Investors Can Expect From This Potential Grower?
seekingalpha.com - May 18 at 4:43 PM
Syndax down 22% on mid-stage entinostat dataSyndax down 22% on mid-stage entinostat data
seekingalpha.com - May 17 at 4:40 PM
Syndax Pharmaceuticals Presents Updated Phase 2 Cancer-Drug Test ResultsSyndax Pharmaceuticals Presents Updated Phase 2 Cancer-Drug Test Results
www.nasdaq.com - May 17 at 9:21 AM
Syndax (SNDX) Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDASyndax (SNDX) Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA
www.streetinsider.com - May 17 at 9:21 AM
Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab)Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab)
finance.yahoo.com - May 17 at 9:21 AM
Syndax Pharmaceuticals: Is This A Multi-Bagger In The Making?Syndax Pharmaceuticals: Is This A Multi-Bagger In The Making?
seekingalpha.com - May 13 at 4:49 PM
Edited Transcript of SNDX earnings conference call or presentation 8-May-18 8:30pm GMTEdited Transcript of SNDX earnings conference call or presentation 8-May-18 8:30pm GMT
finance.yahoo.com - May 10 at 9:27 AM
Syndax Pharmaceuticals beats by $0.17, misses on revenueSyndax Pharmaceuticals beats by $0.17, misses on revenue
seekingalpha.com - May 9 at 9:14 AM
Syndax Pharmaceuticals (SNDX) CEO Briggs Morrison on Q1 2018 Results - Earnings Call TranscriptSyndax Pharmaceuticals' (SNDX) CEO Briggs Morrison on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 9:14 AM
Syndax: 1Q Earnings SnapshotSyndax: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 9:14 AM
Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Clinical and Business UpdateSyndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Clinical and Business Update
finance.yahoo.com - May 8 at 4:44 PM
Syndax to Announce First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 8, 2018Syndax to Announce First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 8, 2018
finance.yahoo.com - May 1 at 9:07 AM
Syndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual MeetingSyndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual Meeting
finance.yahoo.com - April 25 at 4:41 PM
Syndax to Present at the 2018 American Association for Cancer Research Annual MeetingSyndax to Present at the 2018 American Association for Cancer Research Annual Meeting
finance.yahoo.com - April 21 at 9:02 AM
Technical Perspectives on Biotech Stocks -- Syndax Pharma, Teligent ...Technical Perspectives on Biotech Stocks -- Syndax Pharma, Teligent ...
www.prnewswire.com - April 11 at 4:39 PM
Here's Why Syndax Pharmaceuticals Is Soaring TodayHere's Why Syndax Pharmaceuticals Is Soaring Today
finance.yahoo.com - March 14 at 4:41 PM
Syndax Pharmaceuticals Reports Fourth Quarter 2017 Financial Results and Provides Clinical and Business UpdateSyndax Pharmaceuticals Reports Fourth Quarter 2017 Financial Results and Provides Clinical and Business Update
finance.yahoo.com - March 5 at 4:49 PM
Syndax Pharmaceuticals Inc (NASDAQ:SNDX): Does The -16.61% Earnings Decline Make It An Underperformer?Syndax Pharmaceuticals Inc (NASDAQ:SNDX): Does The -16.61% Earnings Decline Make It An Underperformer?
finance.yahoo.com - March 5 at 10:21 AM
Syndax Pharmaceuticals Announces Participation at Two Upcoming Investor ConferencesSyndax Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
finance.yahoo.com - March 5 at 10:21 AM
Syndax to Announce Fourth Quarter and Year-end 2017 Financial Results and Host Conference Call and Webcast on March 5, 2018Syndax to Announce Fourth Quarter and Year-end 2017 Financial Results and Host Conference Call and Webcast on March 5, 2018
finance.yahoo.com - February 26 at 9:36 AM
Syndax Announces Presentations at the 2018 American Association for Cancer Research Annual MeetingSyndax Announces Presentations at the 2018 American Association for Cancer Research Annual Meeting
finance.yahoo.com - February 22 at 9:11 AM
Syndax Pharmaceuticals (SNDX) Reports Immuno-Oncology Clinical Trial Collaboration with AstraZenecaSyndax Pharmaceuticals (SNDX) Reports Immuno-Oncology Clinical Trial Collaboration with AstraZeneca
www.streetinsider.com - February 2 at 3:26 PM
Syndax Pharmaceuticals (SNDX) Reports Immuno-Oncology Clinical Trial Collaboration with AstraZeneca - StreetInsider.comSyndax Pharmaceuticals (SNDX) Reports Immuno-Oncology Clinical Trial Collaboration with AstraZeneca - StreetInsider.com
www.streetinsider.com - February 2 at 6:28 AM
Pre-Open Movers 02/01: (OPGN) (AFMD) (ICPT) Higher; (EGOV) (ONCS) (UPS) Lower (more...)Pre-Open Movers 02/01: (OPGN) (AFMD) (ICPT) Higher; (EGOV) (ONCS) (UPS) Lower (more...)
www.streetinsider.com - February 1 at 3:24 PM
Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZenecaSyndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca
finance.yahoo.com - February 1 at 3:24 PM
This page was last updated on 9/21/2018 by MarketBeat.com Staff

Featured Article: Market Capitalization

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel